Medivir to present at the Carnegie Company Event

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the company will present at the Carnegie Company Event on Thursday, November 28.

CEO Jens Lindberg will provide an update on the fostrox program in advanced hepatocellular carcinoma (HCC). The presentation will take place at 11.35-12.00 CET and include the recently presented data at the ESMO conference and how they strengthen the ambition to make fostrox + Lenvima® the first, approved treatment option in second-line HCC.

The presentation is live broadcasted and can be followed via the link HERE.
The presentation will be available on Medivir’s website after the meeting.

Datum 2024-11-27, kl 10:30
Källa MFN
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.